Joseph Atkins
Optometrist · Lafayette, LANPI 1346271384
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.8%), speaking fees and education — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 68.1% of it on its own, with 14 other manufacturers making up the rest. Among optometrist clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $61.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$4K
- Alcon$382
- Glaukos Corporation$289
- Mallinckrodt Hospital Products Inc.$199
- Dompe US, Inc.$152
- Sight Sciences, Inc.$148
- plus $659 from 9 others
What the payments were for
- Speaking & faculty fees$2,52044%
- Food & beverage$3,02553%
- Education$1002%
- Entertainment$882%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 52 | $3,904 |
| Alcon | 13 | $382 |
| Glaukos Corporation | 2 | $289 |
| Mallinckrodt Hospital Products Inc. | 5 | $199 |
| Dompe US, Inc. | 3 | $152 |
| Sight Sciences, Inc. | 1 | $148 |
| Tarsus Pharmaceuticals, Inc. | 2 | $128 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $123 |
| Biotissue Holdings Inc. | 4 | $120 |
| Optos, Inc. | 2 | $88 |
| Rxsight Inc | 1 | $75 |
| AbbVie(2 entities) | 4 | $74 |
| Novartis | 1 | $26 |
| Carl Zeiss Meditec, Inc. | 1 | $13 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,733 in reported general payments places this provider in the 90th percentile of 500 optometrist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 14 | $9,538 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 16 | $861 |
| Latanoprost | 68 | $597 |
| Timolol Maleate | 17 | $45 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Lafayette
- Leanne GilderLafayette$8K
- Laurie SicardLafayette$7K
- Mitchell BroussardLafayette$6K
- Catherine GuidryLafayette$5K
- Pamela TheriotShreveport$207K
- Joshua DavidsonGonzales$189K
- Jeffrey WilhiteMarrero$86K
- Christopher WrotenHammond$59K
- James LamarNew Orleans$45K
- John McCallLogansport$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.